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The skin is the first line of defense against pathogen and other environmental pollutant.
The body is constantly exposed to reactive oxygen species (ROS) that stimulates
inflammatory process in the skin. Many studies have linked ROS to various
inflammatory skin diseases. Patients with skin diseases face various challenges with
inefficient and inappropriate treatment in managing skin diseases. Overproduction of ROS
in the body will result in oxidative stress which will lead to various cellular damage and alter
normal cell function. Multiple signaling pathways are seen to have significant effects during
ROS-mediated oxidative stress. In this review, microalgae have been selected as a source
of natural-derived antioxidant to combat inflammatory skin diseases that are prominent in
today’s society. Several studies have demonstrated that bioactive compounds isolated
from microalgae have anti-inflammation and anti-oxidative properties that can help
remedy various skin diseases. These compounds are able to inhibit production of pro-
inflammatory cytokines and reduce the expression of inflammatory genes. Bioactive
compounds from microalgae work in action by altering enzyme activities, regulating
cellular activities, targeting major signaling pathways related to inflammation.
Keywords: microalgae, bioactive compounds, anti-inflammation, anti-oxidant, skin diseaseINTRODUCTION
The skin is the outermost layer and considered the largest organ in the human body. It plays an
important protective role by providing a major boundary between the host and the external
environment (Benson and Watkinson, 2012). The skin is also well equipped with effective defenses
against pathogens and other environmental pollution (Wang H. et al., 2013). Exogenous threats
such as UV radiation and oral introduction of potentially toxic dietary and drug metabolites, all
of these factors may influence the health and appearance of the skin (Sander et al., 2004). The bodyin.org July 2020 | Volume 11 | Article 10861
FIGURE 1 | Reactive oxygen species (ROS)-mediated activation of various
cell signaling pathways in the skin. Chemical irritants, allergens, or
inflammatory agents that cause the production of ROS during the
pathogenesis of various skin disease and activation of a various number of
signaling pathways. Signaling pathways with the most significant effects are
MAPK/AP-1, NF- kb, and JAK-STAT pathways. Activation of these pathways
will result in protein damge, cell apoptosis, DNA modification, lipid
peroxidation, and production of proinflammatory mediators.
Choo et al. Anti-Inflammatory Properties of Microalgaeis constantly exposed to these environmental agents and
endogenous metabolites that may have either short-term or
long-term side effects to the host. Because of that, they may
directly or indirectly promote the production of reactive oxygen
species (ROS) that stimulate the inflammatory process in the
skin (Kohen, 1999; Trouba et al., 2002). The surface of the skin is
constantly exposed to ROS as its first line of defense against
pathogens and external pollutants. Many studies have linked
ROS to various inflammatory skin diseases (atopic dermatitis
[AD], psoriasis, and vitiligo), skin aging, and carcinogenesis
(Briganti and Picardo, 2003; Sander et al., 2004; Okayama, 2005).
Skin diseases are the fourth most common cause of non-fatal
disease burden and 18th leading cause of global disability-adjusted
life years (DALYs) worldwide within the year of 2010–2013
(Karimkhani et al., 2017). Dermatitis (consisting of atopic,
seborrheic, and contact categories) is the highest burden among
of the skin conditions, make up a total of 9.3 million DALYs
(Karimkhani et al., 2017). Skin diseases may present similarly across
racial and ethnic groups; however, some features may be either
more prominent in patients with darker skin (Mei-Yen Yong and
Tay, 2017; Kaufman et al., 2018). Besides that, patients with skin
diseases face challenges with ineffective and inappropriate
treatment, such as oral antihistamines, oral corticosteroids, or
traditional medicines, which may have low potency or have
significant side effects for certain individual (Lopez Carrera et al.,
2019). Therefore, natural derived ingredients may be potential in
combating against skin diseases (Jahan et al., 2017).
ROS consist of reactive molecules and free radicals that are
oxygen based and are often associated with the principle of
oxidative stress, which suggests that ROS induce cell damage by
interfering with lipids, proteins, and DNA within the body
(Cross, 1987). ROS are produced during the reduction of
molecular oxygen as follow:
O2 + 1e
− +H+ ! H2O ! H+ + O2 −
H2O + 1e
− + H+ ! H2O2
H2O2 + 1e
− +H+ ! H3O2 ! H2O + OH
OH + 1e− +H+ ! H2O
Superoxide anion (O2
-), hydroxyl radicals (OH.), hydrogen
peroxide (H2O2), and molecular oxygen (O2) at low levels in the
body are involved in various cellular process such as, cell
proliferation, apoptosis, immune responses, and cell differentiation
(Kumar and Pandey, 2015). In contrast, overproduction of ROS
will result in oxidative stress, which will further lead to altered
metabolism, dysregulated signal transduction, and biomolecular
cell damage, which cause pathological changes in normal cell
function (Trouba et al., 2002). Biomolecular damage that occurs
as a result of increasing ROS levels has considered as lipid
peroxidation, DNA mutation, enzyme inactivation/activation, and
protein oxidation/degradation. Such damages will usually cause
further damaging effects as the result of ROS. Thus, the amount
of ROS level is displayed to be hormesis, whereby low doseFrontiers in Pharmacology | www.frontiersin.org 2stimulation showing beneficial effects and high dose stimulation
showing toxic effect (Di Meo et al., 2016).RELATIONSHIP BETWEEN OXIDATIVE
STRESS AND SKIN INFLAMMATION
DISEASE
Inflammation triggers when the body detects the presence of
pathogens or irritants that are present in the body. Many studies
have linked that there is correlation between oxidative stress and
various inflammatory skin disease. Evidence shows that ROS-
mediated oxidative stress stimulates the production of oxidative
products which can cause damage to proteins, triggers cell
apoptosis, cause DNA modification, lipid peroxidation, and
promotes the release of proinflammatory mediators, such as
cytokines and chemokines, which may be the main cause of
several inflammatory skin disease to occur (Meffert et al., 1976).
In addition, ROS acts as a secondary messenger in influencing
cellular signal transduction pathways proinflammatory signaling
pathways and modulate the expression of several gene involved
in inflammation (Finkel and Holbrook, 2000). The most
significant effects were seen in MAPK/AP-1, NF-kb, and JAK-
STAT signaling pathways during early stage of every
inflammatory disorders (Figure 1) (Dhar et al., 2002; WolkJuly 2020 | Volume 11 | Article 1086
Choo et al. Anti-Inflammatory Properties of Microalgaeet al., 2004; Kim et al., 2005; Wang et al., 2006). Activation of
these signal transduction cascades results in the production of
growth factors, cytokines, neurotransmitters, and other signaling
molecules, thus leading to cell proliferation, differentiation,
and apoptosis.FIGURE 2 | Simplified schematic of pathogenesis of atopic dermatitis (AD)
with skin barrier defect. Impact of infections, allergens and itch leads to
upregulation of inflammatory pathways.MECHANISM OF ANTI-OXIDANTS IN SKIN
Anti-oxidants functions to delay or prevent ROS-induced
cellular damage. They can help to reduce oxygen radicals,
inhibiting chain initiation reactions, binding catalysts that
generate ROS, and attenuating hydrogen radicals (Trouba
et al., 2002). Anti-oxidants can be categorized as enzymatic
and non-enzymatic in the intracellular and extracellular
environment (Frei et al., 1988).
Rice-Evans and Diplock (1993) proposed that anti-oxidants
had two principle mechanism of action against ROS. The first is a
chain breaking mechanism whereby anti-oxidant donates an
electron to the free radical that is present in the systems. The
second mechanism involves removal of ROS/RNS initiators by
quenching chain-initiating catalyst. Anti-oxidants may cultivate
different mechanism to combat radicals in the biological systems
such as, electron donation, metal ion chelation, co-antioxidants,
or by gene expression regulation (Krinsky, 1992).SKIN DISORDERS
Atopic Dermatitis
Atopic dermatitis (AD) is a chronic, itching, inflammatory
disease and is predominantly between 10 and 20% of pediatric
population (Kowalska-Olędzka et al., 2019). Symptoms of
AD appear in 60% of patients before reaching 1 year of
age (Kowalska-Olędzka et al., 2019). AD is believed to be
caused by combination of genetic and environmental factors
(Eigenmann and Calza, 2000; Hill and Hosking, 2004). It is
characterized by having papules and plaques. The earliest lesion
is a small erythematous papule or papulovesicle. These papules
may then later become erythematous plaques with clinical
features of weeping, crusting, or scaling, depending on the
severity of the lesions form (Simpson, 2010). The most
problematic symptom of AD is itch. The “itch-scratch” cycle
involves scratching on affected areas on the skin to relieve AD
associated itch and would further worsen the disease (Figure 2).
These symptoms would usually accompany with sleep
disturbance and social stigma of visible skin disorder, therefore
having negative impact to the quality of life to the patient and
family (Bender et al., 2008).
Symptoms of AD often reduces the barrier function of the
skin as demonstrated by elevated trans-epidermal water loss and
increase permeation of environmental irritants and allergens.
Antigen-presenting cells (APC), such as Langerhan’s cells,
process antigens and present it to lymphocytes, where the
process will stimulate helper T-cells into the skin. These cells
then stimulate the production of proinflammatory cytokines intoFrontiers in Pharmacology | www.frontiersin.org 3the inflamedarea.Thiswill thenenable the activationof imbalanced
growth factors, cytokines (IL-1, IL-6, GM-CSF, TNF-a), and
chemokines that interfere with the normal mechanism of the
innate immune system of the skin (Nesterova et al., 2019).
Overproduction levels of cytokines will oppose the mechanism of
innate immunity in the skin and consequently cause secondary
bacterial infection at site of inflammation (Albanesi and Pastore,
2010). Patients with AD are prone to acquiring secondary
cutaneous infections such as Staphylococcus aureus infections.
These infections are usually present in the form of impetigo
or folliculitis due to further worsening from scratching
(Leyden et al., 1974).
Other than avoiding irritants and moisturizing the skin with
emollients, the most common method to treat AD is by applying
topical corticosteroids (Spergel, 2008). Topical corticosteroids
produce instant results in short-term treatment on skin itching
and inflammation of skin. However, long-term usage of such
treatment may lead to adverse effects, such as skin atrophy and
telangiectasia (Van der Aa et al., 2010). Besides that, long term
use of topical corticosteroids will cause thinning of the stratum
corneum, therefore allowing irritants and allergens entry into
the skin.
Psoriasis
Psoriasis is a chronic autoimmune disease characterized by
raised, red scaly plaques (Lowes et al., 2014). This disease
affects 2–3% of the world population, resulting in psychological
stress and poor quality of life (Perera et al., 2012). The most
common type of psoriasis is psoriasis vulgaris which accounted
about 85–90% of all cases of psoriasis. Psoriasis is caused by
hyperproliferation of keratinocytes and infiltration of activatedJuly 2020 | Volume 11 | Article 1086
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psychological stress, bacterial infections, or injury (Dika et al.,
2007; Lowes et al., 2007).
Several studies have identified that overexpression of various
cytokines occurred in psoriasis, such as interleukins (ILs), tumor
necrosis factor (TNF), and interferon-g (IFN-g) (Figure 3)
(Nickoloff et al., 2007). Furthermore, development of psoriasis
was closely linked to complex cellular interactions among
epidermal keratinocytes, leukocytes, neutrophils, dendritic cells,
and activated T cells, growth factors, cytokines, and chemokines
(Nickoloff et al., 2007).
The mitogen-activated protein kinase signaling pathways
composed of extracellular-regulated kinase (ERK1/2 and
ERK3/4) (Seternes et al., 2004), Jun N-terminal kinase (JNK)
(Davis, 1994; Cano and Mahadevan, 1995), p38 kinase (Cano
and Mahadevan, 1995; Cobb and Goldsmith, 1995), and big
mitogen activated protein kinase 1 (BMK1) (Kato et al., 2000).
Several studies have demonstrated that ROS may trigger
pathogenesis of psoriasis through ERK1/2, JNK, and p38
MAPK pathways (Takahashi et al., 2002; Johansen et al., 2005;
Yu et al., 2007). However, no reports have found that ERK3/4
and BMK1 pathway being involved in the pathogenesis of
psoriasis due to oxidative stress as of now.
During cell stimulation, Ikb (inhibitor of kb) proteins are
rapidly phosphorylated and degraded by the proteasome,
the unbound NF-kb translocate into the nucleus to regulate
multiple gene expressions (Hayden, 2004). These genes may
encode for TNF super family, IL-1, IL-6, IL-8, iNOS, major
histocompatibility complex class 1 (MHC class 1) antigens,FIGURE 3 | Simplified schematic of pathogenesis of psoriasis with activation
of Th22 and Th17 cells.
Frontiers in Pharmacology | www.frontiersin.org 4E-selectin, and vascular cell adhesion molecule 1 (VCAM-1),
which are mostly involved in psoriasis (Wajant et al., 2003;
Schottelius et al., 2004).
Although MAPK/AP-1 and NF-kb signaling pathways is
triggered by ROS in the pathogenesis of psoriasis, there is solid
evidence showing that there’s a correlation between these two
signal transduction pathways. This is because the response to
AP-1 is highly stimulated due to the presence of NF-kb and thus
NF-kb positively modulates the expression of c-Fos and AP-1
activity (Stein et al., 1993; Fujioka et al., 2004).
The JAK-STAT signal pathway also plays an important role in
immune and inflammatory responses (Kishimoto et al., 1994).
Studies shown that STAT1 is upregulated by IFN-g and IL-20
and thus induce inflammatory mediators in a type 1 cytokine
pathway model of psoriasis pathogenesis (Wang et al., 2006).
Another study had demonstrated that STAT3 pathway is
believed to play a role in the pathogenesis of psoriasis where
STAT3 is activated by IL-22 and result in the increased
expression of b-defensin 2/3 (Wolk et al., 2004).
The most common conventional treatment of psoriasis
consists of corticosteroids, Vitamin D analogues, phototherapy,
and systemic treatments (Novelli et al., 2014). However, long-
term usage of conventional treatments may cause severe health
issues to patients, such as poor tolerability and cumulative
toxicity (Rahman et al., 2012). Topical glucocorticosteroids and
Vitamin D analogues are commonly used to treat psoriasis by
regulating keratinocyte function and inflammatory response.
Nonetheless, long term treatment of corticosteroid can cause
several health issues, such as cutaneous atrophy, short remission
duration, and cause psoriasis to be rebound (Chong and
Fonacier, 2015). Regardless of their reduce side effects in
comparison to corticosteroid, vitamin D analogues still fail to
have a rapid activation in the body (Smith and Barker, 2006).
Another widely used treatment for psoriasis, methotrexate, due
to its reasonable price and its high efficacy (Boehncke, 2003;
Heydendael et al., 2003). However, prolonged usage of the drug
may cause patients to suffer liver fibrosis and cirrhosis (Deng
et al., 2016).Vitiligo
Vitiligo is a skin disorder characterized by depigmented macules
from melanocyte dysfunction in the epidermis (Boniface et al.,
2017). Vitiligo affects approximately 0.5–1% of the world
population and both genders are equally affected (Taïeb and
Picardo, 2009). Studies have suggest that destruction of
melanocytes is the main cause of the pathogenesis of vitiligo
(Poole et al., 1993). Oxidative stress may be the main pathogenic
reason in melanocyte loss (Maresca et al., 1997; Schallreuter, 1999).
Patients in active phase of vitiligo has high levels of ROS in
the epidermal layer, primarily consists of hydrogen peroxide
(H2O2) and peroxynitrite (Schallreuter et al., 1991; Schallreuter
et al., 1999). This damage is due to local and systemic imbalance
in enzymatic and non-enzymatic anti-oxidant systems in the
skin (Shajil and Begum, 2006). Studies have demonstrated that
vitiligo patients have high levels of tetrahydrobiopterin (6BG4)
and the isomer 7BH4 in the epidermis and inhibits the enzymesJuly 2020 | Volume 11 | Article 1086
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(Schallereuter et al., 1994; Hasse et al., 2004).
In melanocytes, the alteration of calcium homeostasis due to
the increase in level of H2O2 systemically and locally would
indirectly interfere with the intake of L-phemylalanine, an
amino acid precursor of tyrosine (Schallreuter et al., 2007).
Proopiomelanocortin-derived bioactive peptides ACTH and a-
MSH plays crucial role in melanogenesis by activating a cascade
of intracellular signals that promotes relevant enzymes in
melanin production, such as tyrosinase and tyrosinase-related
proteins 1 and tyrosinase-related proteins 2. Presence of ROS
may oxidize or inhibit these signaling pathways for melanin
synthesis (Tachibana, 2000).
Accumulation of ROS may induce DNA damage, lipid
peroxidation, increased production of proinflammatory, and
antimelanogenic cytokines (Mahendra et al., 2019a; Mahendra
et al., 2019b). Altered enzymes that play a key role in
melanogenesis may show partial or complete dysfunction due
to damage done from oxidative stress (Denat et al., 2014).
Recent studies have linked Nrf2-anti-oxidant response element
(ARE) pathway being affected by oxidative stress in regulating
vitiligo skin homeostasis (Jian et al., 2011; Jian et al., 2014; Qiu
et al., 2014). Nrf2-ARE is an anti-oxidant pathway that regulates the
transcription of stress-related cytoprotective genes and thus
protecting cells from radical molecules (Jian et al., 2011). One
example of such gene is the heme oxygenase-1 (HO-1). Another
study had shown that vitiligo melanocytes have decrease HO-1
expression and abnormal redox balance due to reduced Nrf2
nuclear translocation and transcriptional activity. For this reason,
the same studies were conducted in a clinical setting and showed
that vitiligo patients have low expression levels of HO-1 gene when
compared to healthy controls (Jian et al., 2014).
Corticosteroids are still the first line therapy for vitiligo and
can use either as topical or systemic treatment. Topical
corticosteroids help to decrease the destruction of melanocyte
and repopulate melanocyte and melanin production (Bleehen,
1976; Hann et al., 1993). However, corticosteroids still pose to
have various side effects which includes skin atrophy,
telangiectasia, and striae distensae, steroid folliculitis, and acne
formation on the skin (Speeckaert and van Geel, 2017). In
contrast, oral corticosteroid therapy in moderate doses helps in
arresting the progression of vitiligo (Speeckaert and van Geel,
2017). Side effects include acne formation, disturbance in sleep
patterns, weight gain, agitation, hypertrichosis, and menstrual
abnormalities, when consume on a long-term basis (Radakovic-
Fijan et al., 2001).
Phototherapy is also a common treatment to induce
repigmentation in vitiligo patients. Phototherapy involves
usage of both UVA and UVB to promote melanocyte
migration and proliferation (Wu et al., 2007). Common side
effects patients may receive from psoralen and ultraviolet a
(PUVA) treatment includes erythema, pruritus, headache, and
nausea (Valkova et al., 2004). Patients may also suffer from
second-degree burns when incorrect radiation doses from
phototherapy (Herr et al., 2007). PUVA also carries a higherFrontiers in Pharmacology | www.frontiersin.org 5risk in gaining non-melanoma skin cancer and melanoma (Park
et al., 2003; Patel et al., 2009).MICROALGAE AS NATURAL SOURCE OF
BIOACTIVE COMPOUNDS
Microalgae are unicellular microorganism that can be found in
freshwater or marine environments. They are autotrophic as they
are capable to undergo photosynthesis with the aid of sunlight, they
can convert water and carbon dioxide into organic compounds like
terrestrial plants (Metting, 1996). Microalgae have many advantages
over terrestrial plants as they are fast growing, easily cultivate, and
do not compete directly with agricultural crops. Microalgae are
capable to live in extreme conditions and environment by adopting
surviving strategies by producing various bioactive compounds with
diverse structure and unique activity to counter environmental
stress (Christaki et al., 2012). Therefore, microalgae has drawn
great attention as candidate for natural products to be use in the
medical, pharmaceutical, cosmetic, and biofuel industries
(Sathasivam et al., 2019).
Microalgae produce various bioactive compounds that exhibit
potential pharmacological effects, including anticancer,
antidiabetic, anti-inflammatory, and anti-oxidative activities (Fu
et al., 2017). These bioactive compounds include fatty acids,
phycobiliproteins, chlorophylls, carotenoids, and vitamins.
Microalgae-derived bioactive compounds have been proven to
be able to overcome inflammatory skin disorders, given by their
tremendous structural diversity and biological availability.
Furthermore, the culture condition of microalgae can be easily
manipulate to favor production of specific bioactive compounds
by addition or removal of certain nutrients (Fu et al., 2017).
Bioactive compounds of microalgae from primary metabolism
are directly involved in cell growth and reproduction. Primary
metabolites frommicroalgae are usually consists of carbohydrates,
lipid, and proteins (Wen et al., 2015). Secondary metabolites have
gained several attentions over the past decades due to their wide
health benefiting properties. These metabolites are mainly
involved in adaption of microalgae to the environment (Bourgaud
et al., 2001). In most microalgae species, the bioactive compounds
are accumulated in the form of their biomass; while in some cases,
they are excreted into the medium.
Protective Effects of Microalgae Against
Inflammatory Skin Diseases
Microalgae extracts possess anti-inflammatory properties as they
are able to inhibit production of pro-inflammatory cytokines and
reduce the expression of inflammatory genes (Robertson et al.,
2015). Bioactive compounds from microalgae works in various
ways in inhibiting skin inflammation which includes altering
enzyme activities, regulating cellular activities, nitric oxide
synthase (NOS), and targeting major signaling pathways, such
as NF-ƙb and MAPKs pathway (Hussain et al., 2016). Both of
these pathways are major mediators of various inflammatory
producer. Besides having anti-inflammatory, microalgae extractsJuly 2020 | Volume 11 | Article 1086
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et al., 2016).KEY METABOLITES IN MICROALGAE
Carotenoids
Carotenoids are mostly found in plants, marine algae, fungi, and
bacteria. Carotenoids are divided into two classes, carotenes and
xanthophylls (Sathasivam and Ki, 2018). Xanthophylls contain
oxygen group in their structure while it is absent in carotenes.
Carotenoids have a common chemical backbone which
composed mainly of polyene chain with a long conjugated
double bond system. The ending of the chain may be
terminated with cyclic groups containing oxygen-bearing
substitutes. The electron-rich conjugated system of the polyene
and its cyclic end groups determine the functional anti-oxidant
properties of carotenoids (Martin et al., 1999).
In microalgae, carotenoids play a role in protecting the
chlorophyll from long-term exposure of light by scavenging ROS,
phototropism, and photoaxis (Esteban et al., 2009). Carotenoids can
scavenge harmful radicals through three different ways, which are,
electron transfer, radical adduct formation, and hydrogen atom
transfer (Burton and Ingold, 1984; Rice-Evans et al., 1997; Paiva
and Russell, 1999; Skibsted, 2012).
Car + R• ! Car•þ + R− (electron transfer)
Car + R• ! ½Car⋯R• (radical adduct formation)
Car + R• ! Car( −H)• + RH (hydrogen atom transfer)
Carotenoids are potential to be used to treat and control
chronic inflammation as research shown that they are capable to
inhibit pro-inflammatory cytokines (Zhang et al., 2014).
Carotenoids are able to regulate chronic inflammatory disorder
by inhibiting the effects from nitric oxide production, pro-
inflammatory cytokines, expression of pro-inflammatory genes,
and pro-inflammatory enzyme activities (Hussain et al., 2016).Astaxanthin
Astaxanthin is a lipid soluble pigment and is classified as a
xanthophyll. It is a secondary metabolite and is mainly found in
the marine environment as a red-orange pigment. Astaxanthin is
primarily synthesized naturally by microalgae, zooplankton,
crustaceans, and certain species of fish, such as salmonids.
Although astaxanthin can be synthesized from plants, bacteria,
and microalgae, one particular species of microalgae, namely
Haematococcus pluvialis, is known to produce the highest
content of astaxanthin (Boussiba, 2000).
Astaxanthin has reported to have higher bioactive properties
than zeaxanthin, lutein, and b-carotene. This is due to the
presence of a keto- and hydroxyl group on each end of its
structure. Because of its unique structure, astaxanthin has the
potential to be used in promoting human health. The polar end
groups of astaxanthin are able to quench free radicals, the doubleFrontiers in Pharmacology | www.frontiersin.org 6bond chains of the structure help remove high-energy electrons.
Because of its unique structure, astaxanthin has a higher anti-
oxidant activity than other carotenoids (Higuera-Ciapara et al.,
2006). When it come to the characteristics of its existence,
astaxanthin is polar in nature and hence its rate in absorption
is rather easy with a moderate consumption. Besides the integrity
of membrane is preserved by conveniently instilling themselves
in between bilayers. With this feature, astaxanthin can also
preserve the functionality of the mitochondria that lead to the
protection of the redox state of the body (Wolf et al., 2010;
Kidd, 2011).
Studies on rat models on the effects of astaxanthin on
lipopolysaccharide-induced inflammatory reactions shows that
astaxanthin (100 mg/kg) has a higher anti-inflammatory activity
than that of 10 mg/kg of prednisolone, a common anti-
inflammatory drug. Further results showed that astaxanthin
inhibits production of NO, prostaglandin E2 (PGE2), TNF-a,
and interleukin-1b, and also blocks the NOS enzyme in RAW
264.7 cells (Ohgami et al., 2003).
Other reports stating that human neutrophil treated with 5
mM astaxanthin has improved phagocytic and microbicidal
activity. Besides that, oxidative damage to proteins and lipids
in human neutrophil were significantly lower after astaxanthin
treatment due to the fact that astaxanthin is effective in
quenching ROS (Macedo et al., 2010).
Another study has demonstrated that U937 cells (human
lymphoma cell line) pre-incubated in 10 mM astaxanthin before
inducing H2O2 showed lower cytokines levels than cells that were
not treated with astaxanthin. In addition, cells that were pre-
incubated in astaxanthin had shown higher levels of SHP-1
(protein tyrosine phosphate), an enzyme that removes
phosphate groups from phosphorylated tyrosine residue from
proteins, and lower levels of NF-ƙb expression (Speranza
et al., 2012).
Studies also shown that HaCaT keratinocytes treated with
astaxanthin were able to decrease UV-induced release of
migration inhibitory factor (MIF), 1L-1b, and TNF-a at both
the protein and mRNA levels. Astaxanthin treatment were able
to reduce the UVB-induced production of pro-inflammatory
cytokines, thus inhibited the cells from undergoing apoptosis and
also protected the skin from inflammation. Furthermore,
astaxanthin treatment significantly reduced the UVB-induced
caspase-3 and caspase-9 activity while no reduction was observed
in UVC-induced caspase-3 activity. Therefore, astaxanthin
treatment may have a stronger protective effect against UVB-
induced apoptosis than UVC-induced apoptosis. Besides that,
astaxanthin also decreases the expression levels of inducible
nitric oxide synthase (iNOS) and cycloosygenase-2 (COX-2)
and decreases production of PGE2 in UV-induced HaCaT
keratinocyte (Yoshihisa et al., 2014).
Lutein
Lutein is a yellow pigment and is classified as a xanthophyll.
Lutein helps protect green microalgae from ROS damage.
Microalgae have been considered the main natural source for
lutein production as they produce higher lutein content compare
to plants source (Lin et al., 2015). Dunaliella salina has beenJuly 2020 | Volume 11 | Article 1086
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growth conditions (Fu et al., 2012). Other microalgae strain, such
as Chlorella sorokiniana and Chlorella prothecoides have also
been suggested as source of lutein production by manipulating
growth conditions (Shi et al., 2002; Cordero et al., 2011). Lutein
has been widely studied in the treatment of macular
degeneration. However, studies suggest that lutein is capable of
quenching oxygen radicals and scavenging free radicals (Jahns
and Holzwarth, 2012).
Microsporine-Like Amino Acid
Studies have proven that mycosporine-Gly possess anti-oxidative
activity and may protect against skin inflammation caused by
UV radiation. Anti-oxidative activity of mycosporine-Gly
(0.3mM) extracted from Chlamydomonas hedleyi was high and
UV-elevated COX-2 gene were suppressed. This shown that the
regulation of COX-2 may be link to the oxidative process from
mycrosporine-Gly (Suh et al., 2014).
Sterols
Sterols are found in almost all living organism. Microalgae
produce a wide variety of sterols and plant derivative sterols
are termed as phytosterols. Phytosterols extracted from
microalgae found to possess anti-inflammatory properties
(Yasukawa et al., 1996). A study demonstrated that extract
from the microalgae, Nannochloropsis oculata, was able to
induce anti-inflammatory effect on RAW 264.7 cells. Anti-
inflammatory of the extract were accomplished by the decrease
expression of iNOS and COX-2 proteins (Sanjeewa et al., 2016).
Polysaccharides
The cell walls of microalgae are rich in sulphated polysaccharide
(SPs) and it exhibit various health benefiting properties such as
anticoagulant, anti-oxidant, antiviral, anticancer, and anti-
inflammatory activities (Wang J. et al., 2013; De Jesus Raposo
et al., 2015). Therefore, SPs from microalgae have potential to be
incorporate in nutraceutical, pharmaceutical, and cosmeceutical
products. The biological and pharmacological activities of SPs are
due to the complex interaction of the structure feature, such as the
sulphation level, distribution of sulphate groups along the
backbone of the molecule, molecular weight, sugar residue
composition, and stereochemistry (Damonte et al., 2004; Ghosh
et al., 2009). Several studies have demonstrated SPs for its potent
anti-inflammatory properties. For instance, a study on Chlorella
stigmatophora and Phaeodactylum tricornutum had demonstrated
anti-inflammatory activity on paw edema. Carrageenan extracted
from both microalgae strain had better anti-inflammatory activity
on in vivo and in vitromodels compared to the anti-inflammatory
drug, indomethacin (Guzmán et al., 2003). Besides that, inhibition
of leukocyte migration has a correlation with the anti-
inflammatory activity of polysaccharides. Leukocyte movement
to site of injury promotes cytokine release and production of nitric
oxide. SPs from Porphyridium had demonstrated to inhibit the
movement and adhesion of polymorphonuclear leukocytes and
development of erythema in vivo (Matsui et al., 2003).
Besides inhibiting inflammatory cytokines and chemokines,
studies also shown that P. cruentum is capable of inhibitingFrontiers in Pharmacology | www.frontiersin.org 7biomembrane peroxidation and for its immunomodulatory
activities (Sun et al., 2009; Sun et al., 2012). Studies had
demonstrated that low molecular fractions of exopolysachharide
(EPS) from P. creuntum can stimulate the production of
macrophages and nitric oxide (NO). NO is a free radical
produced by phagocytes and plays a role in the immune system.
In addition, other study also justified that SPs from cyanobacteria
can promote immune system by triggering the cell and humor
stimulation (Namikoshi and Rinehart, 1996).
Conclusion
ROS are prevalent in nature and are constantly produced at
minute amount in aerobic systems. Living organism are capable
to produce a wide range of anti-oxidant to eliminate or inhibit
ROS to maintain homeostasis. Our body is constantly exposed
to various pro-oxidants from the environment, such as
consumption of drugs, solar radiation, pollutant, food
additives, synthetic cosmetic products, which are capable to
induce ROS in skin. ROS mostly target DNA, proteins, and
lipid-rich membranes to induce toxicity effects to the body. Such
damages to the skin may result in numerous skin diseases
ranging from AD to vitiligo. Therefore, discovery of novel
anti-inflammatory drugs from natural products that could
potentially eliminate or inhibit ROS could bring new insight
for biomedical research and industry (Fernando et al., 2016).
Microalgae has become the main interest among consumers and
industry due to their ability to produce a wide variety of bioactive
compounds with health promoting properties and anti-
inflammatory can be isolated from them. However, further
pre-clinical investigation is still needed to understand the
mechanism of these novel compounds in tackling skin
inflammation diseases.AUTHOR CONTRIBUTIONS
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